SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Gynecologic Oncology Consultation — Eva Perón — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Eva Perón |
|---|
| Date of birth | 1919-05-07 |
|---|
| Identifiers | MRN HR-ML025-SYN-TD; SSN (made up) 000-25-7316 |
|---|
| Document date | 1951-02-17 |
|---|
| Author | Henrietta Osei-Bonsu, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
A friable, exophytic cervical mass about 4 cm across in a 31-year-old woman who has never had cervical screening, with four months of bleeding after intercourse and between periods and iron deficiency anemia. A punch biopsy, HPV test and cytology were taken today. Please see her on the day the biopsy result is given, to confirm the diagnosis, stage the disease, advise on treatment by stage, and counsel her about fertility and ovarian function, and help us give her the result as she has asked. [S]
Urgency: Urgent, within one to two weeks, on the day of her biopsy result. [S]
Questions for the consultant:
- If the biopsy confirms cancer, what is its type, and what is its FIGO 1943 stage, and which imaging is needed to stage it?
- What treatment do you recommend for that stage, and is she a candidate for surgery or for chemoradiation?
- What are her options to preserve fertility or ovarian function before treatment, and how much time do they need?
- How should her bleeding, pain and anemia be managed before and during treatment?
- Will you help us give her the diagnosis directly, in Spanish, in the way she has asked, and plan how information is shared with her from here on?
History of Present Illness
Ms. Perón, a 31-year-old foundation director, is seen at the request of Dr. Barragán on the day she was told her biopsy result. The consultation is in Spanish through a professional medical interpreter, at her wish. She has had four months of bleeding after intercourse and between periods, with heavier periods, tiredness and a pelvic ache. She has never had cervical screening and was not vaccinated against HPV. She has no children and has not been pregnant. Dr. Barragán gave her the diagnosis in Spanish earlier in this visit; she has heard it, asked whether it can be cured, whether she can keep working, and whether she could have children, and asked that I explain the next steps to her directly. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- She was born Eva María Ibarguren on May 7, 1919, in Los Toldos, a village in the Province of Buenos Aires, Argentina; her marriage contract later gave her birth date as May 7, 1922. [D]
- She married Juan Perón on October 22, 1945, and became Argentina's first lady after his election in 1946. Her work for the poor made her a powerful political figure, and she is best known as Evita. [D]
- Her medical ordeal began in January 1950, when she was 30: she fainted and underwent an appendectomy. Despite persistent weakness and anemia from vaginal bleeding, she delayed further tests. [D]
- The Pap smear, which can find cervical cancer at its earliest stage, was developed in 1942, but in 1950 it was not yet standard medical care in the United States or Argentina. [D]
6 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth once daily, with vitamin C-rich food or juice, apart from tea and dairy | One tablet by mouth once daily | Oral route | 1951-02-09 to 1951-08-17 | completed | S |
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours when needed for pelvic pain, no more than 6 tablets a day | One or two tablets every 6 hours when needed, no more than 6 a day | Oral route | 1951-02-09 | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Bleeding after intercourse and between periods, with heavier periods, for about four months, with tiredness and a dull pelvic ache. Never had cervical screening. Speculum examination shows a friable, exophytic mass about 4 cm across on the cervix that bleeds on contact. Punch biopsy, HPV test and cytology taken; urgent gynecologic oncology consultation booked | resolved | confirmed |
N93.8 | S — Synthetic presenting problem linked to her documented abnormal bleeding with anemia; superseded by the diagnosis at the consultation. |
| Iron deficiency anemia from chronic blood loss: hemoglobin 9.4 g/dL, mean cell volume 72 fL, ferritin 6 ng/mL, with tiredness and breathlessness on stairs | active | confirmed |
D50.0 | S — Synthetic modern finding linked to her documented anemia from vaginal bleeding. |
| Invasive squamous cell carcinoma of the cervix, HPV 16 positive: an exophytic tumor about 4.5 cm across with clinical involvement of the left parametrium, not reaching the pelvic wall; pelvic MRI and PET-CT ordered for FIGO 1943 staging. Synthetic modern episode linked to her documented cervical cancer | active | confirmed |
C53.9 | S — Synthetic modern diagnosis made at the gynecologic oncology consultation. |
Physical Exam
Vital signs recorded on 1951-02-17; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| General | Pale; pulse 90, blood pressure 112/70 |
| Lymph nodes | No inguinal or supraclavicular nodes |
| Pelvic | With her consent and a chaperone: a friable exophytic tumor about 4.5 cm across replacing the cervix; colposcopy of the vagina shows no spread to the vaginal walls; on rectovaginal examination the left parametrium is thickened and nodular but does not reach the pelvic wall; the right parametrium and the rectal mucosa are free |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1951-02-17 | Creatinine [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.5-1.1 mg/dL | Normal | S |
| 1951-02-17 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1946)/1.73 sq M | 117 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1951-02-17 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 | {score} | | | S |
| 1951-02-17 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | {score} | | | S |
| 1951-02-17 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | {score} | | | S |
Assessment
- Squamous cell carcinoma of the cervix (C53.9). Invasive squamous cell carcinoma of the cervix related to HPV 16, about 4.5 cm with clinical spread into the left parametrium: at least FIGO 1943 stage IIB on examination. FIGO 1943 allows imaging to assign stage: a pelvic MRI defines local extent and an FDG PET-CT looks for nodal and distant spread, which would change the radiation fields and the stage. With parametrial spread, radical hysterectomy is not advised; the standard treatment, with intent to cure, is pelvic external beam radiation with weekly cisplatin, followed by image-guided brachytherapy, completed within eight weeks, because a longer overall time lowers the chance of cure. Kidney function allows cisplatin. HIV testing is recommended at diagnosis. Chemoradiation will end her ability to carry a pregnancy and will very likely end ovarian function; egg or embryo freezing needs about two weeks of stimulation and would delay treatment slightly, and laparoscopic ovarian transposition can sometimes preserve hormone function; any later pregnancy would need a gestational carrier. The decision is hers. Bleeding is now light; if it becomes heavy, vaginal packing or a few early radiation fractions control it. Anemia should be corrected before radiation with iron, and hemoglobin watched weekly during it. Acetaminophen is the right analgesic; anti-inflammatory painkillers should be avoided with cisplatin. The diagnosis was given to her first, in her language, and she asked to hear everything; I explained the plan to her directly and answered each of her questions honestly. [S]
- Iron deficiency anemia (D50.0). From chronic tumor bleeding; oral iron is reasonable now that the bleeding is lighter, with transfusion only if hemoglobin falls sharply or she has symptoms. [S]
Data reviewed: Dr. Barragán's intake note. Cervical punch biopsy: invasive squamous cell carcinoma. HPV test positive for HPV 16; cytology with squamous cancer cells. Hemoglobin 9.4 g/dL, ferritin 6 ng/mL. Creatinine 0.7 mg/dL, eGFR 117 today. PHQ-9 9 and GAD-7 9 today. [S]
Plan of Treatment
- Pelvic MRI and FDG PET-CT within ten days to assign the FIGO 1943 stage. [S]
- HIV and hepatitis C tests now. [S]
- If staging confirms stage IIB without nodal or distant spread: pelvic external beam radiation 45 Gy in 25 fractions with cisplatin 40 mg/m2 weekly, then image-guided high-dose-rate brachytherapy, all within eight weeks. [S]
- Before treatment, her decision about egg or embryo freezing (reproductive endocrinology within days if she wants it) or ovarian transposition; treatment should not be delayed beyond about two weeks. [S]
- Continue ferrous sulfate and acetaminophen; no anti-inflammatory painkillers during cisplatin; weekly blood count, creatinine and magnesium during treatment. [S]
- Oncology social worker from today; PHQ-9 and GAD-7 at diagnosis, before treatment, mid-treatment and after. [S]
- All discussions with her directly, in Spanish with a professional interpreter when the clinician does not speak Spanish; information shared only with the people she chooses. [S]
- After treatment: PET-CT at about three months, a vaginal dilator, and hormone therapy if ovarian failure occurs. [S]
- Discussed with Dr. Barragán, who was present. The diagnosis, the staging plan and the likely treatment were explained to Ms. Perón in Spanish through the interpreter, and she was given written information in Spanish. She chose to tell her family herself; no one else has been given information. She decides who receives this note. [S]
- Follow-up: Gynecologic oncology review with the staging results in about two weeks, jointly with Dr. Barragán, to confirm the stage and her treatment and fertility decisions. [S]